首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1140713

2022-2029 年 Western Blot 处理器的全球市场

Global Western Blotting Processors Market - 2022-2029

出版日期: 2022年10月20日 | 出版商:

DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

在蛋白质组学研究中越来越多地采用蛋白质印迹处理器推动市场增长

蛋白质印迹处理器市场主要由蛋白质组学和基因组学研究驱动。Western印迹是分子生物学和蛋白质组学中最常用的技术之一。Western blotting是分子生物学和蛋白质组学中最常用的技术之一，但由于该技术是一个连续的框架，每一步都会发生变化和不准确，限制了该技术的可重复性和不准确性，并可能降低可靠性。蛋白质组学可以分析和识别翻译后修饰、蛋白质-蛋白质相互作用和蛋白质周转。随着对高效和个性化医学的开发越来越关注，全球对蛋白质印迹处理器的需求正在增加。

对个性化医疗的日益关注也有助于预测期内的市场增长。越来越多地采用个性化治疗癌症正在推动采用蛋白质印迹处理器。个性化医疗有可能提供最高的反应和最高的安全边际，以确保更好的患者护理。个性化医疗有可能在降低成本的同时改善医疗保健的多个方面，这有望成为市场增长的积极指标。根据个性化医学联盟的数据，生物製药研究人员预测，未来五年正在开发的个性化药物数量将增加 69%。

地理渗透。

北美是预测期内的主要地区。

该研究按地区分析了全球市场的蛋白质印迹处理器市场，包括北美、南美、欧洲、亚太地区、中东和非洲。

蛋白质印迹处理器在北美的价值和数量占全球最大份额，其次是欧洲和亚太地区。2022年北美Western Blot Processor市场由美国主导。这是由于莱姆病和艾滋病毒的流行率增加、研究资金增加、转基因作物产量增加以及研究会议增加。美国的几个主要参与者正在通过推出新的学习中心来帮助他们发展市场。例如，2021 年 1 月，Bio-Rad Laboratories 推出了蛋白质印迹学习中心和在线学习平台，为研究人员改进实验蛋白质印迹提供信息和指导。该学习中心位于 bio-rad.com。该中心提供有关蛋白质印迹科学、最佳实践、提示和技巧、实验故障排除指南等的全面信息。

此外，预计亚太地区将在预测期内显示出西方印迹处理器市场最快的增长率。中国在市场上占主导地位，据估计，在预测期内，印度在亚太地区的蛋白质印迹处理器市场将出现大幅增长。

竞争格局。

由于 Western Blot Processor 品牌众多，Western Blot Processor 市场是一个竞争激烈的市场。主要的蛋白质印迹处理器製造商有 Bio-Rad Laboratories, Inc.、Cell Signaling Technology、Advansta Inc.、Li-Cor Biosciences、Bio-Techne Corporation、GE Healthcare、Cytoskeleton Inc.、PerkinElmer Inc.、F. Hoffmann-La Roche Ltd.。 , Merck KGaA., Bio-Key, Bio-Rad, Cell Signaling Technology Inc.主要参与者正在采用新产品发布和扩张战略来促进蛋白质印迹处理器的全球增长。一些主要的主要参与者正在遵循併购策略来扩展他们的业务。例如，2021 年 4 月，Bio-techne 完成了对 Asuragen, Inc. 的收购。此次收购有助于扩大公司一流的分子诊断和研究产品的产品组合，包括基因筛查、肿瘤检测试剂盒和分子控制。同样在 2022 年 7 月，Bio-Techne 宣布已完成对 Namocell, Inc. 的收购。此次收购增加了一个易于使用的单细胞分选和移液平台，该平台对细胞友好并保持细胞活力和完整性。2022年1月，Bio-techne宣布商业发布用于jess自动化免疫印迹系统的高灵敏度荧光检测Stellar NIR/IR模块。这个新模块能够检测低丰度蛋白质，同时在同一检测通道内多路復用多种分析物。该模块为蛋白质印迹中的荧光检测灵敏度设立了新的行业标准。

COVID-19 的影响。它将对 Western Blot Processor 全球市场产生积极影响。

在 COVID-19 中蛋白质印迹处理器使用范围扩大的背景下，蛋白质印迹处理器市场的规模预计将在 2020 年扩大。应考虑使用蛋白质印迹来确认筛查测试（如 ELISA）中的阳性或临界阳性结果。蛋白质印蹟的另一个好处是识别可能成为疫苗开发基础的抗原。蛋白质印迹法用于确定 COVID-19 康復患者血清识别的蛋白质抗原，以及哪些病毒应作为单价疫苗或疫苗混合物的一部分，尤其是在不使用减毒活病毒时。由此可见，大流行期间对蛋白质印蹟的需求增加了，蛋白质印迹处理器市场的需求也增加了。因此，在 COVID-19 大流行期间，对蛋白质印迹处理器的需求增加，导致 2020 年的销售额增加。

Western Blot Processor 全球市场报告提供了大约 61 个市场数据表、54 个数字和 170 页的结构。

Market Overview

Western Blotting Processors Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029)

Western blotting is an analytical technique used to separate and detect specific proteins based on the relative molecular mass of proteins. Western blotting processors are devices used to do western blotting techniques to attain high sensitivity and specificity, facilitating detection of preferred protein with a concentration nearly ten times lesser than the threshold of detection. The results attained with the conventional western blotting processors are relatively unreliable, tedious and require technical expertise, which is addressed by the automated western blot processors. Certain factors leading the market growth include the increasing prevalence of HIV/AIDS, the increasing R&D expenditure by pharmaceutical and biotechnology companies, and untapped opportunities in emerging markets.

Market Dynamics: Rising adoption of western blotting processor in increasing proteomics research drives market growth

The market for western blotting processors is considerably driven by proteomics and genomics research. Western blotting is one of the most commonly used techniques in molecular biology and proteomics. Because it is a sequential framework, differences and inaccuracies could even take place at any stage, decreasing this particular method's reproducibility and reliability. Proteomics approaches include the characterization and identification of post-translational modifications, protein-protein interaction, protein turnovers, and more. With the rising focus on the development of efficient, personalized medicine, the demand for western blotting processors is increasing globally.

Also, increasing focus on personalized medicine helps to grow the market in the forecast period. The increasing adoption of personalized medicines for cancer is augmenting the adoption of western blotting processors. Personalized medicine has the potential to provide the best response and highest safety margin to ensure better patient care. Personalized medicine has the potential to improve several aspects of healthcare while lowering costs, which is expected to be a positive indicator of the growth of the market. According to Personalized Medicine Coalition, biopharmaceutical researchers predict a 69% increase in the number of personalized medicines in development over the next five years.

Market Segmentation: Disease diagnostics segment will project the fastest growth in the market throughout the forecast period

Based on the application, the western blotting processors market has been classified into biomedical & biochemical research, disease diagnostics, agriculture, and others.

The disease diagnostics segment dominated the western blotting processor market in 2022. This is due to a rise in the increasing incidences of target diseases, such as Hepatitis and Lyme disease, across the globe. A diagnostics test is a kind of medical test performed to aid in the diagnosis or detection of a disease. Disease diagnostic tests are used to provide prognostic information on people with established diseases. Healthcare professionals use symptoms and signs as clues that can help to determine the most likely diagnosis when illness is present. Moreover, the use of these devices to identify specific protein molecules from a mixture of protein samples in proteomics and genetic science are certain key factors expected to drive market growth in the forecast period.

Based on the end-user, the western blotting processors market has been classified into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others.

Academic & research institutes lead the market throughout the forecast period. Several research activities ongoing in the academic & research laboratories are augmenting the demand for western blotting processors. The major demand is driven across the developed and emerging nations, such as the United States, United Kingdom and Germany.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the western blotting processors market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

North America dominated the global western blotting processors market with the largest share in value and volume globally, followed by Europe and the Asia Pacific. The United States dominated the North American western blotting processors market in 2022. It is owing to the increasing prevalence of Lyme disease and HIV, the rise in research funding and growing production of genetically modified crops, and the rising number of research conferences. Some major key players in the United States help grow the the market by launching new learning centers. For instance, in January 2021, Bio-Rad laboratory launched its Western Blot Learning Centre and online learning platform, which provide information and guidance to help researchers to improve their experimental western blotting. This learning Centre is available on bio-rad.com. This Centre offered comprehensive information on the science of western blotting, best practices, tips and techniques, and guidance on troubleshooting experiments.

Moreover, Asia Pacific is expected to project the fastest growth rate in the western blotting processors market during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific western blotting processors market during the forecast period.

Competitive Landscape:

The western blotting processors market is highly competitive, owing to the large presence of western blotting processors brands. The key western blotting processors players include Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA. The crucial players are adopting new product launches and expansion strategies for global growth in the western blotting processors. Some major key players follow merger and acquisition strategies to expand their business. For instance, in April 2021, Bio-techne completed the acquisition of Asuragen, Inc. This acquisition helped to increase the product portfolio of best-in-class molecular diagnostic and research products like genetic screening, oncology testing kits, and molecular controls. Also, in July 2022, Bio-Techne announced it had completed the acquisition of Namocell, Inc. This acquisition adds easy-to-use single-cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. In January 2022, Bio-techne announced the commercial release of high sensitivity fluorescent detection stellar NIR / IR modules for jess's automated western blotting system. This new module allowed the detection of low abundance proteins while multiplexing multiple analytes within the same detection lane. This module sets a new industry standard for western blotting fluorescence detection sensitivity.

COVID-19 Impact: Positive impact on the global western blotting processors market.

An increase in the market value of western blotting processors is expected in 2020, backed by the increasing application of western blotting processors in COVID-19. Western blots should be considered for confirming a positive or borderline-positive result from a screening test, such as an ELISA. An additional benefit of Western blots would be to identify antigens that could form the basis for developing a vaccine. Western blot technic used to determine which protein antigens are recognized by sera from patients recovering from COVID-19 in order to better identify those components of the virus that should be part of a monovalent vaccine or a vaccine cocktail, especially if a live, attenuated virus is not used. These factors indicated that the need for western blotting increased during the pandemic owing to increasing demand for the western blotting processors market. Therefore, the demand for western blotting processors increased amid the COVID-19 pandemic, which in turn, increased its sales in 2020.

The global western blotting processors market report would provide an access to approximately 61 market data tables, 54 figures and 170 pages

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by End User
3.4. Market Snippet by Region

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of HIV/AIDS
  - 4.1.1.2. Rise in R&D spending by pharmaceutical companies
- 4.1.2. Restraints:
  - 4.1.2.1. Emergence of alternatives
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
7.3. Market Attractiveness Index, By Product Segment
- 7.3.1. Consumables*
  - 7.3.1.1. Introduction
  - 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 7.3.2. Instruments

8. By Application

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
- 8.3.1. Biomedical & Biochemical Research*
  - 8.3.1.1. Introduction
  - 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 8.3.2. Disease Diagnostic
- 8.3.3. Agriculture
- 8.3.4. Others

9. By End User

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
9.3. Market Attractiveness Index, By End User Segment
- 9.3.1. Academic & Research Institutes*
  - 9.3.1.1. Introduction
  - 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 9.3.2. Pharmaceutical & Biotechnology Companies
- 9.3.3. Diagnostic Centers
- 9.3.4. Others

10. By Region

10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. U.S.
  - 10.4.6.2. Canada
  - 10.4.6.3. Mexico
10.5. Europe
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. Germany
  - 10.5.6.2. U.K.
  - 10.5.6.3. France
  - 10.5.6.4. Italy
  - 10.5.6.5. Spain
  - 10.5.6.6. Rest of Europe
10.6. South America
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.6.6.1. Brazil
  - 10.6.6.2. Argentina
  - 10.6.6.3. Rest of South America
10.7. Asia Pacific
- 10.7.1. Introduction
- 10.7.2. Key Region-Specific Dynamics
- 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.7.6.1. China
  - 10.7.6.2. India
  - 10.7.6.3. Japan
  - 10.7.6.4. Australia
  - 10.7.6.5. Rest of Asia Pacific
10.8. Middle East and Africa
- 10.8.1. Introduction
- 10.8.2. Key Region-Specific Dynamics
- 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Western Blotting Processors Market- Company Profiles

12.1. Bio-Rad Laboratories, Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Key Highlights
- 12.1.4. Financial Overview
12.2. Bio-Techne Corporation
12.3. Advansta Inc.
12.4. Cell Signaling Technology
12.5. Li-Cor Biosciences
12.6. Cytoskeleton Inc.
12.7. GE Healthcare
12.8. PerkinElmer Inc.
12.9. Merck KGaA
12.10. F. Hoffmann-La Roche Ltd. (List Not Exhaustive)

13. Premium Insights

14. DataM Intelligence

14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

2022-2029 年 Western Blot 处理器的全球市场